5.0
30 Nov 2024
Current employee, more than 3 years
Recommend
CEO approval
Business outlook
Pros
Great culture, benefits, strong portfolio and nice people. Strong payer coverage for all products.
Cons
Some growing pains, some favoritism, like most companies. Large geographical responsibilities. Chinese name in USA marketplace . Lack of contracting opportunities for small and mid size oncology providers.